How are new drugs disseminated in Japan? Analysis using the National Database of Health Insurance Claims of Japan

Drug lag refers to the difference in the time of a new drug's approval in different countries; the dissemination of the new drug after approval within the countries is another problem. We examined the nationwide dissemination of 11 cancer drugs approved in Japan between 2011 and 2015 using the...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Tomone, Sugiyama, Takehiro, Imai, Kenjiro, Higashi, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128186/
https://www.ncbi.nlm.nih.gov/pubmed/35266252
http://dx.doi.org/10.1111/cas.15322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128186/
https://www.ncbi.nlm.nih.gov/pubmed/35266252
http://dx.doi.org/10.1111/cas.15322

Ejemplares similares